Search for: "NOVARTIS AG" Results 61 - 80 of 440
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Nov 2015, 9:00 am
(Novartis), a subsidiary of Novartis AG, an international pharmaceutical company headquartered in Switzerland, agreed to pay a whopping $390 million as a "settlement in principle" to resolve a False Claims Act (FCA) suit. [read post]
3 Nov 2015, 9:00 am
(Novartis), a subsidiary of Novartis AG, an international pharmaceutical company headquartered in Switzerland, agreed to pay a whopping $390 million as a "settlement in principle" to resolve a False Claims Act (FCA) suit. [read post]
3 Nov 2015, 9:00 am
(Novartis), a subsidiary of Novartis AG, an international pharmaceutical company headquartered in Switzerland, agreed to pay a whopping $390 million as a "settlement in principle" to resolve a False Claims Act (FCA) suit. [read post]
22 Sep 2007, 5:40 am
The HinduBusinessLine reports: Ranbaxy Laboratories has dropped its patent challenge of Novartis AG's hypertension drug Diovan. [read post]
8 Nov 2009, 9:28 pm
Novartis AG et al. v. [read post]
23 Jan 2009, 9:59 pm
By Jason Derry --Peptimmune and Novartis Sign $500 Million Deal Peptimmune Inc. and Novartis AG recently announced a licensing deal for Peptimmune's multiple sclerosis drug candidate, PI-2301. [read post]
15 Sep 2011, 12:38 pm by eithurburn@getnicklaw.com
Watson Pharmaceuticals and the Sandoz unit of Novartis AG are the latest companies to settle with the federal and several state governments as a result of ongoing litigation brought by Ven-A-Care of the Florida Keys alleging that several manufacturers overcharged Medicaid for prescription drugs by inflating their Average Wholesale Prices. [read post]
22 Sep 2020, 2:15 pm by Tom Lamb
Close followers of the rivalry between the two anti-VEGF agents know that inclusion refers to a newly noted Beovu side effect that practically derailed the drug’s initial launch in age-related macular degeneration (AMD). [read post]
31 Mar 2013, 9:32 pm by Patent Docs
UK Patent No. 2,203,040 to Novartis AG (and the associated Supplementary Protection Certificate (SPC)) protected rivastigmine, a drug used for the treatment of Alzheimer's disease. [read post]
13 Feb 2011, 9:08 pm by Patent Docs
Mylan Pharmaceuticals Inc. et al. 1:11-cv-00127; filed February 10, 2011 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
22 Jul 2012, 9:13 pm by Patent Docs
Sun Pharmaceuticals Industries, Inc. et al. 2:12-cv-04393; filed July 14, 2012 in the District Court of New Jersey • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis Corp.; Novartis AG • Defendants: Sun Pharmaceuticals Industries, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd; Sun Pharmaceutical Industries Ltd. [read post]
29 Jan 2015, 10:31 am
Kleemans (Freshfields Bruckhaus Deringer LLP, Amsterdam) the following news:Rutger KleemansOn 27 January the Hague Court of Appeal (judges Kalden, Brinkman and Van Nispen) ruled in summary proceedings in a case between Novartis AG and Sun Pharmaceutical Industries BV. [read post]
11 Apr 2011, 12:04 pm by Tom Lamb
Risk factors include advanced age, concomitant nephrotoxic medicinal products, concomitant diuretic therapy or dehydration occurring after ACLASTA administration. [read post]
10 May 2010, 9:34 pm by Patent Docs
By James DeGiulio -- Celgene and Novartis Reach Settlement with Barr Laboratories in Ritalin ANDA Suit Celgene Corp. and Novartis AG have reached a settlement with Barr Laboratories Inc. over Barr's attempt to market a generic version of the ADHD drug Ritalin. [read post]
25 Jun 2020, 12:07 pm by Mary Jane Wilmoth
Department of Justice (DOJ) announced Novartis AG (“Novartis”), a global pharmaceutical and healthcare company based in Switzerland, agreed to pay over $225 million to resolve FCPA charges for bribery in Greece. [read post]
2 Apr 2019, 7:39 am by Michael Barber
In an email to Reuters, Novartis AG spokesman Eric Althoff said “We are disappointed in today’s decision and look forward to presenting our case at trial. [read post]
21 Apr 2017, 6:15 am by Joseph Robinson
The Federal Circuit affirmed a Patent Trial and Appeal Board (“Board”) decision finding a patent owned by Novartis AG and Mitsubishi Tanabe Pharma Corp. [read post]
3 Jul 2019, 11:02 am
Barbara Levi Mager is a longtime in-house leader for Swiss pharmaceutical company Novartis International AG and Sandoz, a division of Novartis. [read post]
2 Apr 2013, 12:44 pm by Jack McNeill
In a case that may have world-wide ramifications the Supreme Court of India has ruled in Novartis AG v. [read post]